FXN and Friedreich ataxia: It is further supported by a recent study showing that inhibitors of H3K9 and H3K27 methyltransferases, BIX01294, and GSK126 in FRDA patient fibroblasts disrupted heterochromatin, increasing Fxn protein at the mRNA level [32].